Companies: 10,795·Total market cap: $144.5T
Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals, Inc.

ACUROTCHealthcare● Active
$0.00
+$0.00(+150.00%)
Market Cap$33001
P/E Ratio
52W High$0.01
52W Low$0.0001
Overview

Acura Pharmaceuticals, Inc. (ACUR) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ACUR · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.03acur eps ttm · acur earnings per shareEarnings history
PE Ratio (TTM)acur pe ratio ttm · acur price to earningsPE Ratio deep dive
Revenue (TTM)$1.6Macur revenue ttm · acur annual revenueFull revenue history
Dividend YieldNo Dividenddoes acur pay dividends · acur dividend yieldDividend history
Shares Outstanding44.0Macur shares outstanding · acur floatShares outstanding history
Next EarningsTBAacur earnings date · acur next earningsEarnings history

Financial Snapshot

Full Financials
FY 2021Revenue$1.6M▼ 56.22% YoY
201920202021
acura pharmaceuticals, inc. revenue · acur revenue 2021
FY 2021Net Income-$879000.00▲ +27.24% YoY
201920202021
acura pharmaceuticals, inc. net income · acur profit 2021
FY 2021EPS$-0.02▲ +50.00% YoY
201920202021
acur eps · acura pharmaceuticals, inc. earnings per share 2021
TTM:Revenue: $1.6MNet Income: -$879000.00EPS: $-0.03View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy3 analystsis acur a buy · acur analyst rating
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$0.00Current
$Avg Target
$High
acur price target · acur 12 month forecast

Total: 3 · Buy rate: 100.0%

Stock Performance

Full History
1D+150.00%
1W+150.00%
1M-0.00%
3M-0.00%
YTD+0.00%
1Y-75.00%
5Y-99.88%

About Acura Pharmaceuticals, Inc.

CEORobert Jones
IPO DateMar 28, 1986
Employees9
CountryUS

Acura Pharmaceuticals, Inc. operates as a drug delivery innovator, dedicated to exploring, developing, and bringing to market novel technologies and products aimed at enhancing medication safety acros…

what is acura pharmaceuticals, inc. · acur stock overview · acura pharmaceuticals, inc. company profile · who is acura pharmaceuticals, inc. ceo · acur OTC · acura pharmaceuticals, inc. headquarters · acura pharmaceuticals, inc. business segments

About Stock Overview & Key Data

Acura Pharmaceuticals, Inc. (ACUR) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Mar 28, 1986. As of the latest trading session, ACUR stock price is $0.00, with a market capitalization of $33,001. The stock has returned -75.00% over the past 12 months and +0.00% year-to-date.

According to 3 Wall Street analysts, the consensus rating for Acura Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2021, Acura Pharmaceuticals, Inc. reported revenue of $1.6M and net income of -$879000.00. For detailed data — including Acura Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Acura Pharmaceuticals, Inc. (ACUR) stock price is $0.00. The stock is traded on OTC under the ticker symbol ACUR. The 52-week range is $0.00 – $0.01.

ACUR stock priceACUR quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice